Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. blood vessel
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Blood Vessel Articles & Analysis

141 news found

Hemostemix’s Boots on the Ground in Florida

Hemostemix’s Boots on the Ground in Florida

Hemostemix Inc. (TSX-V: HEM; OTCQB: HMTXF; FSE: 2VF0), an autologous (patient’s own) stem cell therapy company offering VesCell™ (ACP-01) to individuals suffering from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, non ischemic dilated cardiomyopathy, congestive heart failure, and total body ischemia, under Florida’s SB 1768, ...

ByHemostemix Inc.


Cells: Hemostemix ACP-01 and NCP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants

Cells: Hemostemix ACP-01 and NCP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants

Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived cell precursors) may support the long-term ...

ByHemostemix Inc.


Dual Benefits of Compound 17B For Pulmonary Arterial Hypertension

Dual Benefits of Compound 17B For Pulmonary Arterial Hypertension

Despite advances in treatment, current therapies—such as sildenafil, iloprost, and riociguat—primarily focus on reducing symptoms by dilating blood vessels. Unfortunately, these therapies do little to address the underlying inflammatory mechanisms that drive PAH or significantly improve survival rates. ...

BySCIREQ - an emka TECHNOLOGIES Company


CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays

CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays

This new product line offers researchers a powerful tool to study a wide range of diseases affecting the heart, blood vessels, and spleen. CD BioSciences is committed to providing researchers with a comprehensive range of reliable imaging products and analysis services that enable them to make significant contributions to biomedical research. ...

ByCD BioSciences


LDARtools Cold Plunge

LDARtools Cold Plunge

The hustle and bustle of the modern workplace often leaves us longing for new ways to kickstart our day with energy and focus. At the LDARtools office, a refreshing cold plunge has been the top choice. In the pursuit of workplace wellness, a morning ice bath has been an unexpected yet highly effective solution in jumpstarting the day. ...

ByLDARtools


Aflibercept 8 mg in diabetic macular edema first to achieve sustained vision gains with up to 83% of patients extended to 16-24 weeks at two years

Aflibercept 8 mg in diabetic macular edema first to achieve sustained vision gains with up to 83% of patients extended to 16-24 weeks at two years

About DME Diabetic macular edema (DME) is a common complication in eyes of people living with diabetes. DME occurs when high levels of blood sugar lead to damaged blood vessels in the eye that leak fluid into the macula. ...

ByBayer AG


New Offerings Released at Alfa Chemistry: Isoquinoline Alkaloids, Pyridine Alkaloids, and Phenylethylamine Alkaloids

New Offerings Released at Alfa Chemistry: Isoquinoline Alkaloids, Pyridine Alkaloids, and Phenylethylamine Alkaloids

They have strong biological activities and are able to constrict blood vessels in the cardiovascular system and protect against X-ray radiation. ...

ByAlfa Chemistry


CO2 fractional laser in cosmetic dermatology

CO2 fractional laser in cosmetic dermatology

What is a CO2 laser The CO2 laser, which has been used as a medical laser for decades, works by absorbing the energy of the laser and heating the water in the tissue into water vapour, resulting in vaporisation and exfoliation, with the remaining heat producing coagulation, closure of blood vessels and stimulation of type I and type III collagen renewal. ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


New data from pivotal studies with aflibercept 8 mg

New data from pivotal studies with aflibercept 8 mg

About nAMD and DME Neovascular (wet) age-related macular degeneration (nAMD) is an eye disease that progresses rapidly and if left untreated can lead to vision loss in as little as three months. nAMD is one of the leading causes of irreversible blindness and vision impairment around the world. nAMD may affect people as they age. It occurs when abnormal blood ...

ByBayer AG


Effectiveness of the picosecond laser and the precautions after treatment

Effectiveness of the picosecond laser and the precautions after treatment

Picosecond technology penetrates deep into the skin and acts on the skin or blood vessels, causing the damaged tissue to atrophy and die, resulting in darkening and crusting of the skin. ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


New real world study data on reduced risk of adverse kidney outcomes for Xarelto compared to VKA

New real world study data on reduced risk of adverse kidney outcomes for Xarelto compared to VKA

In the prospective observational XARENO study, after a two year follow up period, Xarelto was associated with a reduced risk of adverse kidney outcomes and all-cause mortality in patients with non-valvular atrial fibrillation (NVAF) and advanced chronic kidney disease (CKD), compared to vitamin K antagonists (VKA) XARENO evaluated the impact of Xarelto in patients with NVAF and CKD, given that ...

ByBayer AG


Bayer submits aflibercept 8 mg for marketing authorization in Japan

Bayer submits aflibercept 8 mg for marketing authorization in Japan

About nAMD and DME Neovascular (wet) age-related macular degeneration (nAMD) is an eye disease that progresses rapidly and if left untreated can lead to vision loss in as little as three months. nAMD is one of the leading causes of irreversible blindness and vision impairment around the world. nAMD may affect people as they age. It occurs when abnormal blood ...

ByBayer AG


Presenting Monogenic Heart Failure Disease Modeling in Kyoto

Presenting Monogenic Heart Failure Disease Modeling in Kyoto

https://www.termis.org/wc2018/ On September 7th, CSO speaks about monogenic disease modeling using NuHeartâ„¢ technology during TERM for heart, blood vessel & lung session. 99-O-5: Personalized micro-3D human heart tissues for orphan drug development Tetsuro Wakatsuki,Neil Daily,Pinar Kemanli, Michael Greenberg,Jennifer Strande InvivoSciences, Inc. ...

ByInvivoSciences, Inc. (IVS)


First-Ever Computationally Designed Antibody, Created by Biolojic Design, Entering Human Clinical Trial In Cancer Patients

First-Ever Computationally Designed Antibody, Created by Biolojic Design, Entering Human Clinical Trial In Cancer Patients

We know IL-2 activates the immune system to attack the tumor, but it can also inhibit this attack and in many cases leads to leakage from blood vessels, which can in turn lead to complications like pulmonary edema, which can be life threatening. Knowing this, we programmed our antibody to activate IL-2 to fight the tumor but at the same time halt IL-2's ability ...

ByBiolojic Design, Ltd.


The efficacy of IPL intense pulsed light machine

The efficacy of IPL intense pulsed light machine

It mainly uses IPL intense pulsed light to hit the skin, which has the effect of removing freckles and sealing blood vessels, that is, improving the state of vasodilation. It can also shrink pores, make the skin smoother, and improve the aging state of the skin. ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU

Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU

About nAMD and DME Neovascular (wet) age-related macular degeneration (nAMD) is an eye disease that progresses rapidly and if left untreated can lead to vision loss in as little as three months. nAMD is one of the leading causes of irreversible blindness and vision impairment around the world. nAMD may affect people as they age. It occurs when abnormal blood ...

ByBayer AG


Revacept protects during carotid artery surgery

Revacept protects during carotid artery surgery

All patients required therapy because of dangerous narrowing of the carotid artery and received the nowadays standard basic therapy with the blood platelet inhibitors acetylsalicylic acid (Aspirin©) and/or clopidogrel to prevent renewed vascular occlusion (thrombosis). ...

ByadvanceCOR GmbH


5 Ways OCT Technology Can Benefit Your Practice

5 Ways OCT Technology Can Benefit Your Practice

Robust Scans A standard fundus image lets clinicians view the retina, optic nerve head, macula and retinal blood vessels, but that’s only scratching the surface of potential issues in the back of the eye. ...

ByLombart Instrument, Inc.


HTG Used for First Time in Congenital Heart Defect Surgery

HTG Used for First Time in Congenital Heart Defect Surgery

Infants with CAVC may have trouble feeding and growing at a normal rate and may breathe faster and harder than normal, which causes permanent damage to the lung blood vessels over time. An AV canal can be fixed by surgery where valves and heart chamber walls are reconstructed to ensure proper blood flow. ...

ByEchoPixel, Inc.


XyloCor Therapeutics Commences Phase 2 Component of Phase 1/2 EXACT Clinical Study of XC001 Gene Therapy for Refractory Angina

XyloCor Therapeutics Commences Phase 2 Component of Phase 1/2 EXACT Clinical Study of XC001 Gene Therapy for Refractory Angina

“With a unique mechanism of action that restores blood flow to the heart via the creation of new blood vessels, XC001 represents a novel therapeutic approach for patients who have exhausted other medical and surgical options. ...

ByXyloCor Therapeutics

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT